Skip to Main Content
Lafaine Grant, M.D.

Lafaine Grant, M.D.

Clinical Director of Hepatology, Parkland Memorial Hospital

Professor

School
Medical School
Department
Internal Medicine

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Lafaine Grant, M.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of the Division of Digestive and Liver Diseases.

    Dr. Grant holds a bachelor's degree in biology from Emory University in Atlanta and a post-baccalaureate in biological sciences from Southern Illinois University. She earned her medical degree at Wake Forest University School of Medicine in Winston-Salem, North Carolina, and completed internal medicine residency training at Emory University Hospital. She then completed advanced training through fellowships in gastroenterology at Washington University School of Medicine in St. Louis and in hepatology at Baylor University Medical Center in Dallas. 

    Certified by the American Board of Internal Medicine in gastroenterology and transplant hepatology, Dr. Grant joined the UT Southwestern faculty in 2007. She served as Medical Director of the Digestive and Liver Diseases Clinic at UT Southwestern from 2012 to 2017, and currently serves as Clinical Director of Hepatology at Parkland Memorial Hospital.

    At UT Southwestern, Dr. Grant has served as Co-chair of the Internal Medicine Wellness Committee and as a member of the Racial Equity, Diversity, and Inclusion (REDI) Committee. She is also a member of the Liver Transplant Fellowship Program Evaluation Committee.

    Dr. Grant is a fellow of the American Association For The Study of Liver Diseases and is a member of the  American College of Gastroenterology, the American Gastroenterological Association, the Texas Transplantation Society, the American Society of Transplantation, and the Texas Society for Gastroenterology and Endoscopy.

    Dr. Grant's research interests include liver failure, metabolic dysfunction-associated steatotic liver disease (MASLD), and drug-induced liver injury. Her findings have resulted in numerous clinical trial activities, grant support, regional and local lectures, and peer-reviewed publications. 

  • Education
    Medical School
    Wake Forest University School of Medicine (1997)
    Internship/Residency
    Emory University Hospital (2000), Internal Medicine
    Fellowship
    Washington University School of Medicine (2004), Gastroenterology
    Research Fellowship
    Baylor University Medical Center (2007), Hepatology
  • Research Interest
    • Drug-induced Liver Injury
    • Liver Failure
    • Metabolic Dysfunction-Associated Steatotic Liver Disease
  • Publications

    Star Featured Publications

    Acute Liver Failure Guidelines.
    Shingina A, Mukhtar N, Wakim-Fleming J, Alqahtani S, Wong RJ, Limketkai BN, Larson AM, Grant L, Am J Gastroenterol 2023 Jul 118 7 1128-1153
    Outcomes following liver transplant for alcohol-associated liver disease: comparing alcohol-associated hepatitis and cirrhosis.
    Schroeder M, Pedersen M, Petrasek J, Grant L, Hepatol Commun 2023 May 7 5
    High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
    Rich NE, Parvathaneni A, Sen A, Odewole M, Arroyo A, Mufti AR, Kerr TA, Grant L, Tujios SR, Mayo MJ, Lee WM, Yang JD, Yokoo T, Gopal P, Hoshida Y, Zhu H, Yopp AC, Marrero JA, Singal AG, Dig Dis Sci 2021 May
    More Than a Rash: Recurrent Hepatocellular Carcinoma After Liver Transplantation.
    Moraveji S, Pedersen MR, Chandramouli S, Kerr TA, Grant LM, ACG Case Rep J 2019 Jul 6 7 e00107
    Two-stage liver transplant for ruptured hepatic adenoma: A case report.
    Salhanick M, MacConmara MP, Pedersen MR, Grant L, Hwang CS, Parekh JR, World J Hepatol 2019 Feb 11 2 242-249
    Outcomes of simultaneous liver-kidney transplantation: implications for patient selection.
    Grant L, Tujios S, Singal AG Curr Opin Organ Transplant 2018 Jan
    Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.
    Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, Reddy KR, Seeff LB, Serrano J, Sherker AH, Stolz A, Talwalkar J, Vega M, Vuppalanchi R, Hepatology 2014 Oct 60 4 1399-408
    Clinical and Histological Features of Idiosyncratic Acute Liver Injury Caused by Temozolomide.
    Grant LM, Kleiner DE, Conjeevaram HS, Vuppalanchi R, Lee WM Dig. Dis. Sci. 2012 Dec
    Drug-induced liver injury.
    Grant LM, Rockey DC Curr. Opin. Gastroenterol. 2012 May 28 3 198-202
    Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease.
    Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N, Seki E, Brenner D, Korenblat K, McCrea J Gastroenterology 2006 May 130 6 1564-72
  • Professional Associations/Affiliations
    • American Association For The Study of Liver Diseases (2006)
    • American College of Gastroenterology (2020)
    • American Gastroenterological Association (2001)
    • American Society of Transplantation (2021)
    • Texas Society for Gastroenterology and Endoscopy (2021)
    • Texas Transplantation Society (2016)